Oncology therapeutics market to 2017 high unmet


Published on

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Oncology therapeutics market to 2017 high unmet

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Oncology Therapeutics Market to 2017 - High Unmet Need inthe Management and Treatment of Metastatic Cancers to DriveDrug Developmenthttp://www.aarkstore.com/reports/Oncology-Therapeutics-Market-to-2017-High-Unmet-Need-in-the-Management-and-Treatment-of-Metastatic-Cancers-to-Drive-Drug-Development-177386.htmlYou can also request for sample page of above mention reports onsample@aarkstore.comSummaryCompany, the leading business intelligence provider, has released its latest research,“Oncology Therapeutics Market to 2017 - High Unmet Need in the Management andTreatment of Metastatic Cancers to Drive Drug Development”, which providesinsights into the global oncology therapeutics market and market forecasts until2017. The report provides an in-depth analysis of major oncology indications, which
  2. 2. includes breast cancer, colorectal cancer, Non-Hodgkin’s lymphoma (NHL), Non-Small Cell Lung Cancer (NSCLC), prostate cancer, ovarian cancer, cervical cancer andhead and neck cancer. The report also includes insights into the oncologytherapeutics R&D pipeline. It analyzes the competitive landscape in the oncologytherapeutics market through analysis of M&A, licensing and co-development deals.The report is built using data and information sourced from proprietary databases,primary and secondary research and in-house analysis by Company’s team ofindustry experts.Scope- Data and analysis on the global oncology therapeutics market in the leadinggeographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan.- Annualized market data for the oncology therapeutics market from 2002-2010with forecasts to 2017.- Market data on the therapeutic landscape which covers breast cancer, colorectalcancer, NHL, NSCLC, prostate cancer, ovarian cancer, cervical cancer and head andneck cancer. This includes market size, market share, annual cost of therapy,treatment flow algorithm and branded and generic share.Table of contents:1.1 List of Tables 71.2 List of Figures 112 Oncology Therapeutics Market to 2017 - Introduction 142.1 Company Report Guidance 153 Oncology Therapeutics Market to 2017 - Market Overview 163.1 Revenue Forecasts for Oncology Therapeutics Market 163.1.1 Revenue 163.1.2 Annual Cost of Treatment 223.2 Treatment Usage Patterns 233.3 Drivers and Barriers for Oncology Therapeutics Market 253.3.1 Drivers 253.3.2 Barriers 26
  3. 3. 4 Oncology Therapeutics Market to 2017 - Geographical Landscape 284.1 The US 284.1.1 Revenue 284.1.2 Annual Cost of Treatment 294.1.3 Treatment Usage Patterns 304.2 Top Five Countries of Europe 324.2.1 Revenue 324.2.2 Annual Cost of Treatment 334.2.3 Treatment Usage Patterns 344.3 Japan 364.3.1 Revenue 364.3.2 Annual Cost of Treatment 374.3.3 Treatment Usage Patterns 385 Oncology Therapeutics Market to 2017 - Therapeutic Landscape 405.1 Breast Cancer 405.1.1 Introduction 405.1.2 Survival Rates by Stage 425.1.3 Symptoms 425.1.4 Treatment Flow 435.1.5 Revenue 465.1.6 Annual Cost of Treatment 505.1.7 Treatment Usage Patterns 515.1.8 Drivers and Barriers for Breast Cancer Therapeutics Market 535.2 Colorectal Cancer 55List of FiguresList of Tables are also include.For more Discounted Reports Plz follow The link:Spinal Surgery Devices Market - Global Pipeline Analysis, Competitive Landscapeand Market Forecasts to 2017 - Motion Preserving Spinal Non-Fusion Procedures to
  4. 4. Drive Long Term GrowthOphthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices,Minimally Invasive Procedures in Ophthalmic Surgery to Drive the OphthalmicSurgery MarketPain Management Therapeutics Market to 2017 - Price Competition to IntensifyFollowing Patent Expiries of Lyrica and CymbaltaSearch More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/market-sector-reports/Pharmaceuticals-&-Healthcare-7.htmlNovel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies andVaccines Therapeutic Classes Dominate Late-Stage PipelineOrphan Diseases Therapeutics in Oncology to 2018 - Strongly DiversifiedDevelopmental Pipelines Indicate Long-Term Growth Potential despite ModerateScope of Current Late Stage MoleculesFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com